MedPath

The evaluation of effectiveness of topical chamomile flower extract in sesame oil on clinical symptoms in patients with knee osteoarthritis

Not Applicable
Conditions
Knee osteoarthritis.
Gonarthrosis
Registration Number
IRCT2015013120885N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
99
Inclusion Criteria

the age between 38-65 years; patient's written informed consent for inclusion; recognition of osteoarthritis by the physiatrist according to American college of rheumatology classification criteria; recognition of grade I to III by the physiatrist osteoarthritis according to Kellegren-Lawrence system of classification.

Exclusion Criteria

those who need more than 2 grams of acetaminophen per day; those who need to use other oral or intravenous analgesic; unwillingness to continue to participate in the study; sensitivity to study drugs; patients with other bone joint disorders like rheumatoid arthritis, gout, pseudo gout, infected arthritis, metabolic arthritis, traumatic arthritis, joint replacement, fibromyalgia, non-motor dysfunction related to hip or knee (radiculopathy and neuropathy); concomitant use of glucosamine and chondroitin sulfate; knee corticosteroid injection in the past 3 months; other articular corticosteroid injection in the past 1 month; taking muscle relaxant drugs; pregnancy; oral and local use of corticosteroid in 14 past days; muscle corticosteroid injection in the past 1 month; alcohol addicted; drug abuse; skin diseases in knee; patients with active renal, liver and peptic ulcer diseases; disability to cooperate in filling the forms (cognitive or language disorder).

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: At the beginning of intervention and after 1 week, 2 weeks and 3 weeks after the beginning of intervention. Method of measurement: WOMAC questionnaire.;Joint stiffness. Timepoint: At the beginning of intervention and after 1 week, 2 weeks and 3 weeks after the beginning of intervention. Method of measurement: WOMAC questionnaire.;Function. Timepoint: At the beginning of intervention and after 1 week, 2 weeks and 3 weeks after the beginning of intervention. Method of measurement: WOMAC questionnaire.;The need for acetaminophen 500 milligrams tablets. Timepoint: 1 week, 2 weeks and 3 weeks after the beginning of intervention. Method of measurement: Asking from patients.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath